Why semaglutide makes some people tired — and when it settles

What the STEP 1 trial data show about energy and fatigue

The STEP 1 trial, published in the New England Journal of Medicine, is the foundational evidence base for semaglutide 2.4mg for weight management. Fatigue appeared as a common adverse event in that dataset, reported more frequently in the semaglutide group than in the placebo arm. The pattern is consistent with what investigators see across GLP-1 medicines generally: the effect is typically front-loaded, clustering in the first four to eight weeks and after each dose escalation step.

Why does it happen? Semaglutide slows gastric emptying and meaningfully reduces appetite. Both effects are intentional, but they can reduce total calorie and nutrient intake faster than the body expects. When overall energy availability drops quickly, tiredness follows. It is a physiological response, not a sign that the medicine is harming you.

The NHS semaglutide medicines page lists fatigue among the common side effects, alongside nausea, diarrhoea and headache. If you want to understand exactly why this happens and what it feels like for most people, our page on semaglutide feeling tired explains the experience in detail, which can help you distinguish expected early-treatment tiredness from something that needs clinical attention.

Practical reasons tiredness can linger on semaglutide

A question our prescribers hear most weeks is whether the tiredness will go away, or whether something is wrong. The honest answer is that context matters. Several overlapping factors can extend or deepen fatigue beyond the first few weeks of treatment.

Protein intake often falls because appetite suppression hits all food, not just high-calorie options. Muscle uses protein for repair and energy metabolism; if intake slips significantly, low energy follows. Hydration matters too: nausea can reduce how much people drink, and mild dehydration amplifies tiredness quickly. Sleep quality sometimes shifts with a changing body weight and reduced calorie intake, particularly in the early weeks. And the calorie deficit that produces weight loss is itself an energy cost the body notices.

For practical tips on managing the nausea that often accompanies this phase, the guide to nausea on Wegovy covers strategies many people find useful alongside the fatigue picture. Prioritising protein at each meal, keeping fluids up and avoiding long gaps between eating are the starting points most prescribers recommend, though your own plan should be tailored in conversation with your clinical team.

More detail on how these side effects fit into the broader profile of the medicine is covered on the Wegovy side effects overview.

When tiredness on semaglutide needs medical review

Most fatigue on semaglutide is self-limiting. That said, there are situations where it should be assessed rather than waited out. The MHRA Drug Safety Updates index is the right place to check for any evolving guidance on GLP-1 medicines, and clinicians are expected to keep across it.

Get medical advice promptly if tiredness is severe enough to affect daily functioning and does not improve after two to three weeks at a stable dose. Also seek advice if it is accompanied by significant dizziness, rapid heartbeat, signs of dehydration (dark urine, feeling faint on standing), or gastrointestinal symptoms severe enough to stop you eating or drinking properly. These combinations can signal that the body's fluid and electrolyte balance needs attention, not just lifestyle tweaks.

Persistent fatigue that arrives weeks after a stable period, rather than at the start or after a dose increase, is worth reporting to your prescriber sooner rather than later. It may be unrelated to semaglutide and something else entirely needs ruling out. Patients can also report unexpected side effects directly through the Yellow Card scheme at any point during treatment.

Questions about whether semaglutide is the right treatment for your circumstances, and how Wegovy is priced as a private prescription, are answered on the treatment pages. If you are wondering whether semaglutide can make you feel tired in ways that differ from general fatigue, that page looks at the mechanisms in more depth. A broader view of what Wegovy is and how it works is also available if you are still at the early-research stage.

Treatment decisions are always made with a prescriber. If you are ready to discuss whether semaglutide is clinically suitable for you, check your eligibility with our clinical team — the consultation is free and reviewed the same day by a GPhC-registered Independent Prescriber.